Navigation Links
Protein helps regulate the genes of embryonic stem cells

New research from University of North Carolina at Chapel Hill shows how a protein may be crucial to the regulation of genes in embryonic stem cells. The protein, called "eed," is needed for an essential chemical modification of many genes. Embryos cannot survive without the modification. The findings appear in the May 24 issue of the journal Current Biology.

The research offers an important contribution to a new wave of thinking in genetics: that not all human disease states are due to alterations in DNA sequence. Dr. Terry Magnuson - Sarah Graham Kenan professor, chairman of genetics and director of the Carolina Center for Genome Sciences in UNC's School of Medicine - led the research.

Researchers five decades ago worked to crack the genetic code, the nucleic acid sequence of As, Cs, Gs and Ts making up the DNA of genes. Today, Magnuson's team is trying to unravel a different, newly appreciated mode of inheritance: epigenetics.

"Epigenetic inheritance is heritable information passed down through generations of cells that is not encoded by the DNA sequence," said Nathan D. Montgomery, a graduate student in Magnuson's laboratory and first author of the paper.

This information is in the form of chemical modifications on any of four core histone proteins that group together to provide a molecular scaffold supporting the roughly 35,000 genes in the nucleus of every human cell. Histone modifications affect gene activity and include methylation, in which a methyl component is attached to the histone protein.

The prevailing model is that methylation on histones serves as a docking site for proteins that "read" this histone modification, and it's those proteins that directly have an impact on gene expression - either by activating or silencing a gene.

"Diversity is determined by different types of chemical modifications and also by the number of modifications," Montgomery said. "And those modifications are the unit of epigeneti
'"/>

Source:University of North Carolina School of Medicine


Page: 1 2

Related biology news :

1. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
2. Protein discovery could unlock the secret to better TB treatment
3. Researchers Uncover Key Step In Manufacture of Memory Protein
4. An HIV Protein Plays a Surprising Role in Gene Activation
5. Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease
6. New SARS Protein Linked To Important Cell Doorway
7. The Shapes Of Life: NIGMS Project Yields More Than 1,000 Protein Structures
8. PANTHER Protein Classification System Database 5.0
9. Duke Chemists Isolating Individual Molecules Of Toxic Protein In Alzheimers, Parkinsons Disease
10. Newly Discovered Compound Blocks Known Cancer-Causing Protein
11. UF Researchers Map Bacterial Proteins That Cause Tooth Loss

Post Your Comments:
(Date:11/23/2009)... Current research suggests that a common oral bact...ted report by Nichols et al, "Unique Lipids from a...LR2 Ligands Capable of Enhancing Autoimmunity," ap...Journal of Pathology . , Multiple sclerosis (MS)...ain and spinal cord, affects nearly 1 in 700 peopl...
(Date:11/23/2009)...The only swine vaccine available for the H1N1 viru... with the virus. The vaccination marks the first t...d with the pandemic flu., Iowa State University,...ped the vaccine this summer and has been shipping ...s and Illinois for several weeks., The latest va...
(Date:11/23/2009)...vember 16, 2009 -- A USDOE and USDA study conclude...pland, and cropland pasture could be converted fro...ses, such as switchgrass, from which biomass could...omically viable production of a perennial grass mo...mass are removed annually is expected to require n...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Switchgrass produces biomass efficiently 2UK Identity and Passport Service and IBM Sign 7 year National Biometric Identity Service 28NBIS 29 Contract 9215 1UK Identity and Passport Service and IBM Sign 7 year National Biometric Identity Service 28NBIS 29 Contract 9215 2Obama 3A Too Many Still Die from Diseases That Shouldnt Kill Them 51397 1Obama 3A Too Many Still Die from Diseases That Shouldnt Kill Them 51397 2Mayo Clinic Study Using Structural MRI May Help Accurately Diagnose Dementia Patients 51392 1Mayo Clinic Study Using Structural MRI May Help Accurately Diagnose Dementia Patients 51392 2
...h, and still the University of Wisconsin-Madison S...requests. Since 1998, the school,s oncology depar...r dogs diagnosed with melanoma. Though it is sti...over the nation have wanted to participate in the ...heir pet. , After promising results from work done...
...we carry this activity out through the placenta an...velopment, the lungs of the foetus are filled with... activates this respiration surface. But the main ...ungs are not well formed. Moreover, they often lac...pids that avoids the lungs folding in on themselve...
...billion-base human genome play a vital role in a b...chers from the Wellcome Trust Sanger Institute and...r Medical Research, together with international co...ps of differences implicated in disease as well as... , The Major Histocompatibility Complex (MHC) con...
Other Biology News:Canine cancer vaccine program shows early promise 2Liquid ventilation 2Researchers map of genetic variations implicated in disease 2Researchers map of genetic variations implicated in disease 3
(Date:11/19/2009)...SEATTLE, Nov. 19 Omeros ...ited financial results for the third quarter ended...ptember 30, 2009, Omeros reported a net loss of $3...et loss of $7.4 million, or $2.54 per share, for t...September 30, 2009, the Company reported a net los...
(Date:11/19/2009)..., ,, BETHESDA, Md., Nov. 19 /PRNewswire-Fir...an innovator in biotechnology for diabetes therapy...lting services to food, supplement, biotechnology ...losed the previously reported $6.3 million registe... 2,760,870 shares of its common stock and warrants...
(Date:11/19/2009)...BETHESDA, Md., Nov. 19 S... in biotechnology for diabetes therapy, and a prov...es to food, supplement, biotechnology and pharmace...uesday,s Annual Meeting of Shareholders. ,, At ...(Nasdaq: SPEX ) elected the following members to ...
(Date:11/19/2009)..., MUNSTER, Germany, November 19 /PRNewswire/ ...filed on November 16th, 2009 Flibanserin in the,in...nesia in Parkinson,s,disease for orphan drug statu...EMEA). Levodopa-induced dyskinesia is a complicati...,s and a serious burden to some of those,affected,...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2
... Time -, SAN FRANCISCO, Nov. 10 Medivation, Inc....progress and financial,results for the quarter end...ented another quarter of significant,achievement a... partnering,agreement with Pfizer for Dimebon. Thi...d-class partner capable of maximizing global,comme...
... Discuss the Data and Ongoing ...Nov. 10 Sangamo,BioSciences, Inc. (Nasdaq: SGMO ...1 clinical trial, one of Sangamo,s three Phase 2 c...am to develop SB-509 for diabetic,neuropathy (DN)....f the,drug is well tolerated in subjects with mild...
...es of Non-Core Product Lines -, HOPKINTON, Mass.,...LP ) today reported third quarter financial,result...divestitures: the,sale of its AutoTrace(R) product...he sale of its Pharmaceutical Development and Qual...on for $15.8 million. Revenues for the,quarter wer...
Other Biology Technology:Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update 2Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update 3Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update 4Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update 5Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update 6Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update 7Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update 8Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601 2Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601 3Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601 4Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601 5Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601 6Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs 2Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs 3Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs 4Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs 5Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs 6Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs 7Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs 8Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs 9Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs 10Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs 11
... CyScribe GFX Purification Kit, 25 reactions. For ...beled cDNA.Optimized reagents are packaged togethe...ible and optimized protocols can be used for perfo...abeled nucleotides.Reliable purification using the...
... Purification Kit, 24 reactions. For the generatio...timized reagents are packaged together for complet...mized protocols can be used for performing labelin...tides.Reliable purification using the CyScribe GFX...
Canine serum from Equitech-Bio
UV-NIR light source for USB2000, HR4000, HR2000+ from Ocean Optics
Biology Products: